Skip to Main Content

Paper Details

Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors.
Cancer Chemother Pharmacol
0
2016
Author NameAffiliation
Shubham PantUniversity of Oklahoma Health Sciences Center
Hussein A TawbiThe University of Texas MD Anderson Cancer Center
Sunil SharmaUniversity of Utah Huntsman Cancer Institute
  • 1 - 3

Datasets

Release 1.2